0001070081-13-000002.txt : 20130321
0001070081-13-000002.hdr.sgml : 20130321
20130320185844
ACCESSION NUMBER: 0001070081-13-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20130321
DATE AS OF CHANGE: 20130320
EFFECTIVENESS DATE: 20130321
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-193682
FILM NUMBER: 13706118
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
D
1
primary_doc.xml
X0706
D
LIVE
0001070081
PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
NEW JERSEY
07080-2449
9082227000
DELAWARE
PTC THERAPEUTICS INC
Corporation
true
Stuart
W.
Peltz
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Executive Officer
Director
Claudia
Hirawat
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Executive Officer
Mark
E.
Boulding
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Executive Officer
Allan
S.
Jacobson
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Director
Michael
Schmertzler
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Director
David
P.
Southwell
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Director
Geoffrey
McDonough
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Director
Adam
Koppel
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Director
Michael
Kranda
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Director
Axel
Bolte
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Director
Jerome
B.
Zeldis
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Director
Richard
Aldrich
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080-2449
Director
Biotechnology
Decline to Disclose
- 06
false
2013-03-07
false
true
false
0
Credit Suisse Securities (USA) LLC
816
None
None
11 Madison Avenue
24th Floor
New York
NY
NEW YORK
10010
IL
ILLINOIS
NY
NEW YORK
NJ
NEW JERSEY
CT
CONNECTICUT
DC
DISTRICT OF COLUMBIA
CA
CALIFORNIA
PA
PENNSYLVANIA
MD
MARYLAND
MA
MASSACHUSETTS
false
Wedbush Securities Inc.
877
None
None
1000 Wilshire Boulevard
Los Angeles
CA
CALIFORNIA
90017
NY
NEW YORK
NJ
NEW JERSEY
CT
CONNECTICUT
CA
CALIFORNIA
MA
MASSACHUSETTS
false
59999448
59999448
0
false
32
3149970
0
0
false
PTC THERAPEUTICS, INC.
/s/ Mark E. Boulding
Mark E. Boulding
Executive Vice President and Chief Legal Officer
2013-03-20